ライフサイエンスコーパス: benign disease

1 cases (7/28 with proven cancer and 1/12 with benign disease).

2 rgoing ambulatory colectomy for malignant or benign disease.

3 is highly immunogenic yet causes relatively benign disease.

4 ade (>/=GS7) from low-grade (GS6) cancer and benign disease.

5 hyroidectomy, 47% had thyroid cancer and 53% benign disease.

6 a (AEC > 1500/muL) appear to have clinically benign disease.

7 esection for colon cancer approached that of benign disease.

8 table mRNA and benign thyroid sonography had benign disease.

9 screening results and biopsies performed for benign disease.

10 e) were detected in the low-risk patients or benign disease.

11 d the number of women undergoing surgery for benign disease.

12 this patient subset, many will prove to have benign disease.

13 negative control subjects undergoing EUS for benign disease.

14 hepatic or biliary cancers and 161 (9%) for benign disease.

15 lymph nodes obtained from nine patients with benign disease.

16 ) and 32 lymph nodes from nine patients with benign disease.

17 ts with hepatic malignancies from those with benign disease.

18 (n = 63) were women whose biopsies revealed benign disease.

19 nd the United States, varicella is usually a benign disease.

20 ginal carcinoma after total hysterectomy for benign disease.

21 eening in women after total hysterectomy for benign disease.

22 the fibrotic processes accompanying various benign diseases.

23 s who underwent surgery for non-inflammatory benign diseases.

24 m healthy individuals and from patients with benign diseases.

25 that for the women who learned that they had benign disease (-0.154 ln [microg/dL]/hr; 95% CI: -0.197

26 s, while 20 participants were excluded for a benign disease, 1 for unavailability of the endoscopist

27 omen also underwent one or more biopsies for benign disease (11.3%, 26.3%, and 30.3%, respectively).

28 s (27.2%) compared with patients treated for benign disease (14.1%) (P < .001).

29 ening recommendations after hysterectomy for benign disease, (2) total hysterectomy for benign diseas

30 nd 944 from 1998 to 2006 (group II), 24% for benign disease, 76%, cancer.

31 While it mostly remains a benign disease, a fraction of LM patients progresses to

32 Benign disease accounted for the majority of operations

33 Terminal and benign diseases alike in adults, children, pregnant wome

34 Of these, 10 had benign disease and 4 had cancer, 3 on the ipsilateral si

35 THE was performed in 1085 patients, 26% with benign disease and 74% with cancer.

36 ncerous benign disease depend on the type of benign disease and cancer grade.

37 y was performed in 1344 patients (78.4%) for benign disease and in 371 patients (21.6%) for malignant

38 In one patient with benign disease and in one patient with malignant feature

39 that endoscopic therapy may be successful in benign disease and should be considered prior to surgica

40 alization biopsy (group I) or by documenting benign disease and sparing the patient needle localizati

41 a on the risk between total hysterectomy for benign disease and subsequent vaginal carcinoma were org

42 ical cancer-they underwent the procedure for benign disease and they no longer have a cervix.

43 cement in children is almost always done for benign disease and thus requires a conduit that will las

44 leads to the overtreatment of patients with benign disease and to the inadequate treatment of aggres

45 static prostate cancer compared with that of benign diseases and healthy adults.

46 in patients (including young children) with benign diseases and healthy individuals.

47 and differential diagnosis should range from benign diseases and various drug related side effects to

48 erpretation errors, the CT findings mimicked benign disease, and the patients also had underlying lun

49 ip expression profiles of 4400 human normal, benign, diseased, and tumor samples from >60 tissue type

50 r benign disease, (2) total hysterectomy for benign disease as a risk for vaginal dysplasia or carcin

51 imination between GS7 or greater and GS6 and benign disease: AUC 0.77 (95% CI, 0.71-0.83) vs SOC AUC

52 ideal procedure for patients with end-stage benign disease, Barrett's esophagus with high-grade dysp

53 HCM is a relatively benign disease but an important cause of sudden cardiac

54 have improved the diagnosis and treatment of benign disease but have not significantly increased our

55 ovarian cancer (EOC) was confirmed and from benign disease cases randomly selected from the remainin

56 When validated only on the benign disease controls and PDACs collected from ADEPTS,

57 crine and Pancreatic TumourS (ADEPTS) study (benign disease controls and PDACs) and the UK Collaborat

58 t evaluation in NETs (n = 1684) and cancers, benign diseases, controls (n = 731).

59 ferent entity from erosive GERD, with a more benign disease course but less responsiveness to antiref

60 e treatment escalation and those with a more benign disease course.

61 siderable proportion of patients had a more "benign" disease course with >=10 years survival.

62 scriminate prostate cancer from noncancerous benign disease depend on the type of benign disease and

63 s with a diagnosis of CD, UC, malignancy, or benign disease (diverticular disease, Clostridium diffic

64 ures of various malignant tumor subtypes and benign diseases, either visually or with artificial inte

65 survival rates--but also spare patients with benign disease from undergoing unnecessary surgery.

66 l lipid metabolic differences between OC and benign disease, further implicating altered lipid uptake

67 was also lower than in gallstone plus other benign disease group (p < 0.05).

68 Compared with the malignancy and benign disease groups, neither CD nor UC was associated

69 he cause was underlying malignancy in 43 and benign disease in 16.

70 of the global population, causing relatively benign disease in otherwise healthy individuals.

71 L2 were associated with PDAC compared to the benign diseases in both discovery and validation cohorts

72 tric cancer, gastric outlet obstruction, and benign disease.In the area of upper gastrointestinal tra

73 have been increasingly causally connected to benign diseases including rheumatic conditions.

74 Laparoscopic colectomy for benign disease increased from 6.2% in 2001-2003 to 11.8%

75 ortantly, these findings implicate MSLN in a benign disease, indicating that the activation and role

76 V) infection in humans range from the fairly benign disease infectious mononucleosis to life-threaten

77 AIP accounted for almost 26% of all cases of benign diseases involving unnecessary surgery and was ov

78 Historically seen as a benign disease, it is now becoming clear that Plasmodium

79 gnant group), and patients who knew they had benign disease (known benign group).

80 in age distribution among the patients with benign disease, lung cancer, and metastasis, although no

81 Among 13 patients with benign disease (mean follow-up, 17.0 months; range, 1-27

82 KV has previously been known as a relatively benign disease, more recent epidemic events have brought

83 n = 418) and in patients monitored for known benign disease (n = 151).

84 om patients with ovarian cancer (n = 12) and benign diseases (n = 12) were analyzed using the SomaSca

85 (PSA) levels < 20 ng ml(-1), of whom 31 had benign disease (no cancer) and 41 had prostate cancer.

86 Current selection factors for MIDP were benign disease (odds ratio: OR: 1.56, CI: 1.10-2.21) and

87 evolved, resulting in wider applications in benign disease of the esophagus, biliary tree, and pancr

88 Ovarian fibromatosis is a benign disease of the ovary that is rarely included in t

89 The care of benign disease of the stomach and duodenum is also evolv

90 increasing numbers for various malignant and benign diseases of the pancreas and periampullary region

91 t years to resect a variety of malignant and benign diseases of the pancreas and periampullary region

92 ers (n = 38), and outpatients attending with benign diseases of the urogenital tract (n = 20) were us

93 iscrimination of GS7 or greater from GS6 and benign disease on initial biopsy.

94 ignificantly higher electrical activity than benign disease or normal tissues.

95 ith colorectal cancer, and 125 subjects with benign disease or other types of cancer were evaluated.

96 omen in reproductive age from procedures for benign disease or sterilization were selected.

97 from leukocytes and mammary tissue (normal, benign diseases, or malignant tumors) from 87 women with

98 subgrouped into chronic pancreatitis, other benign disease, pancreatic adenocarcinoma, and other can

99 olated hematuria or isolated proteinuria had benign disease processes.

100 (76.2%) patients had surgery for cancer and benign disease, respectively.

101 e cancer samples were distinguished from the benign disease samples with a 95% and 92% sensitivity an

102 oided in 31 patients: 17 of 20 patients with benign disease, seven patients with metastatic disease,

103 t least 20 years postpartial gastrectomy for benign disease should be considered for annual endoscopi

104 for well-differentiated thyroid carcinoma or benign disease should be transplanted in the sternocleid

105 cedure is used more widely, for instance, in benign diseases such as chronic pancreatitis.

106 rthritis is decreasing and that it is a more benign disease than previously recognized.

107 these enzymes in lesions of endometriosis, a benign disease that presents as persistent ectopic sites

108 In contrast, for benign disease, the OR was 2.10 (confidence interval 1.7

109 ginal carcinoma after total hysterectomy for benign disease, though the best-designed research sugges

110 CC, 11 healthy controls, and 9 patients with benign diseases to test the models, sensitivities and sp

111 Current selection factors for ODP or MIDP (benign disease, tumor size, and BMI) do not mitigate the

112 (ERCP) in 59 patients with gallstone, other benign disease, tumour, and primary sclerosing cholangit

113 disease was diagnosed in nine patients, and benign disease was diagnosed in three.

114 Benign disease was present in 93 (96.9%) in the preinter

115 All 11 survivors with benign disease were alive and well (median = 39 mo).

116 Patients undergoing thyroidectomy for benign disease were allocated by a block randomized list

117 wed in 18 patients (17 with cancer, one with benign disease) who had tubular retrocrural structures o

118 Although NASH is most often a benign disease with an indolent course, patients with th

119 DCIS was not consistently distinguished from benign disease with any method.